Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 1,235,455 shares were traded during mid-day trading, an increase of 52% from the previous session's volume of 811,189 shares.The stock last traded at $29.69 and had previously closed at $29.17.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on SNN shares. Canaccord Genuity Group lifted their price objective on Smith & Nephew SNATS from $27.00 to $28.00 and gave the stock a "hold" rating in a report on Thursday, May 1st. Wall Street Zen raised shares of Smith & Nephew SNATS from a "buy" rating to a "strong-buy" rating in a research report on Wednesday, February 26th. Hsbc Global Res cut shares of Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a research note on Friday, April 25th. HSBC lowered Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a research note on Friday, April 25th. Finally, UBS Group downgraded Smith & Nephew SNATS from a "buy" rating to a "neutral" rating in a research report on Wednesday, March 12th. Six research analysts have rated the stock with a hold rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $28.00.
View Our Latest Analysis on Smith & Nephew SNATS
Smith & Nephew SNATS Stock Performance
The stock has a 50-day moving average of $28.34 and a 200 day moving average of $26.99. The firm has a market capitalization of $13.07 billion, a P/E ratio of 13.82, a price-to-earnings-growth ratio of 0.89 and a beta of 0.68. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.89.
Hedge Funds Weigh In On Smith & Nephew SNATS
A number of institutional investors have recently modified their holdings of the stock. Hexagon Capital Partners LLC lifted its stake in Smith & Nephew SNATS by 63.3% in the first quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider's stock valued at $30,000 after buying an additional 406 shares during the period. Richards Merrill & Peterson Inc. increased its stake in Smith & Nephew SNATS by 500.0% in the first quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider's stock valued at $34,000 after purchasing an additional 1,000 shares in the last quarter. Principal Securities Inc. raised its holdings in Smith & Nephew SNATS by 87.6% in the fourth quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider's stock worth $36,000 after purchasing an additional 691 shares during the period. National Bank of Canada FI boosted its position in shares of Smith & Nephew SNATS by 36.5% during the fourth quarter. National Bank of Canada FI now owns 1,667 shares of the medical equipment provider's stock worth $41,000 after purchasing an additional 446 shares in the last quarter. Finally, Bessemer Group Inc. grew its holdings in shares of Smith & Nephew SNATS by 3,471.4% in the 1st quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider's stock valued at $49,000 after buying an additional 1,701 shares during the period. 25.64% of the stock is owned by institutional investors.
About Smith & Nephew SNATS
(
Get Free Report)
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Smith & Nephew SNATS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew SNATS wasn't on the list.
While Smith & Nephew SNATS currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
